Quest (DGX) stock analysis highlights price action trends, analyst upgrades, revenue expansion alongside daily market intelligence and earnings coverage. Quest Diagnostics shares edged up 0.58% to $193.99, remaining in a narrow range below key resistance. The stock continues to trade well above its support level of $184.29, while the $203.69 resistance zone may cap near-term upside. Volume during the session appeared consistent with normal trading activity, suggesting the move lacked strong conviction.
Quest Diagnostics (DGX) Holds Near Resistance After Modest Gains - Fund Manager Survey
DGX - Stock Analysis
3906 Comments
1985 Likes
1
Aava
Senior Contributor
2 hours ago
Free access to US stock insights, technical analysis, and curated picks focused on helping investors achieve consistent returns with controlled risk exposure. We believe in transparency and provide complete analysis behind every recommendation we make. Access real-time data, expert commentary, and actionable strategies designed for investors at every level. Join thousands who trust our platform for smart investment decisions, steady portfolio growth, and professional-grade research at no cost.
š 75
Reply
2
Taegen
Legendary User
5 hours ago
So much creativity in one project.
š 229
Reply
3
Latresia
Returning User
1 day ago
I feel like I should tell someone about this.
š 215
Reply
4
Ume
Influential Reader
1 day ago
The market is consolidating near recent highs, signaling potential continuation.
š 133
Reply
5
Kevious
Consistent User
2 days ago
Market momentum remains intact, with indices trading within defined technical ranges. Consolidation phases suggest investor confidence is stable. Traders should watch for sector rotation and volume trends to gauge future movements.
š 146
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.